The overall prevalence was 13.6% and increased linearly with age as follows: 0% for 9-month-olds, 2.7% for 4-to 12-year-olds, 13.3% for 20-to 30-year-olds, 20.7% for 35-to 50-year-olds, and 33.4% for 65-to 85-year-olds 
C LONAL expansions within the circulating CD8
+ T-cell population have been described in certain chronic inflammatory and infectious diseases. For example, several studies of peripheral blood T cells in rheumatoid arthritis (RA) patients showed a high frequency of CD8 + expansions expressing particular T-cell receptor (TCR)-variable (V) regions (1) (2) (3) . Sequence analysis of the TCR junctional regions indicated the clonal or oligoclonal nature of these expansions. Preferential usage of Va 12.1 (encoded by the TCRAV12S1 gene segment) and Vp3.1 (encoded by the TCRBV3S1 gene segment) suggested the possibility that these clonal expansions arose in response to particular antigens (1) (2) (3) . A high frequency of large, clonal CD8 + expansions has also been reported in the peripheral blood of individuals infected with human immunodeficiency virus (HIV), and it has been presumed that they reflect HIV-specific cytotoxic lymphocytes (4) (5) (6) . Surprisingly, large clonal CD8 + Tcell expansions have also been found in the peripheral blood of many healthy individuals (2, (7) (8) (9) . In some cases, these expansions occupied over 50% of the total CD8 + population and persisted for long periods of time (2, 9) . Their etiology is unknown. Studies of the TCR sequences utilized by clones in identical twins and related individuals have suggested that the clones arose in response to stimulation by a specific antigen (2, 10) .
Increasing age and the aging immune system have been hypothesized to be important in the development of these CD8 + T-cell expansions in healthy individuals. Posnett et al. (9) found a number of elderly (over 65 years of age) individuals with large clonal expansions, whereas these expansions were absent in control cord blood samples. Based on this selective presence in elderly individuals, these expansions were labeled as the T-cell equivalent of benign monoclonal gammopathy. In support of the hypothesis for the importance of age in the development of these expansions, similar CD8
+ clonal expansions have also described in mice, but only in old mice (11) . However, other studies have found large CD8 + clonal expansions in healthy children and young adults (2, 10, 12) . These expansions have also been shown to persist in peripheral blood for long periods of time. The prevalence of clonal CD8 + expansions in relation to age is not known at this time.
The current study was undertaken to determine the importance of age in the development of these CD8 + subset expansions in healthy individuals. We examined the TCR repertoire, demographic characteristics, and infectious disease and vaccination histories of healthy individuals from 9 months of age to persons as old as 85 years. In the large group of 9-month-old children, no expansions were noted, which is consistent with prior reports of the absence of these expansions in cord blood samples. Expansions were uncommon in children and young adults, but their prevalence increased remarkably with increasing age. Multiple expansions were found only in the oldest age group. In this epidemiologic study, no demographic characteristic or history of particular infection stood out as being strongly associated with the presence of these CD8 + T-cell expansions. These results support the importance of increasing age as the most important determinant of susceptibility.
MATERIALS AND METHODS

Study Population
Healthy individuals were recruited from the Denver metropolitan area based on age group. Nine-month-old children were studied as part of a diabetes prevention study being conducted at the University of Colorado Health Sciences Center (Denver, CO) (13) . This study identifies chil-
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dren at high risk for the development of type I diabetes based on MHC type. Subjects for the current study, however, were chosen without regard to HLA status. Children less than 12 years old were asked to participate during a "well child" visit at one large pediatrics practice in Denver. Adult volunteers were recruited through newspaper and advertisements posted at the National Jewish Medical and Research Center (Denver, CO). The advertisement specified that healthy individuals were being sought. In addition, some older individuals were recruited during a regular office visit to a local family practice physician. Peripheral blood samples were obtained after informed consent in accordance with research protocols approved by the Human Subjects Institutional Review Board at the National Jewish Medical and Research Center. The confidential questionnaire, which collected a history of childhood illnesses, immunizations, and past illnesses, was given to volunteers at the time their blood was drawn and was completed at that time or returned using a self-addressed stamped envelope. Questions regarding illnesses and medications on the questionnaire were also used to exclude individuals with possible chronic inflammatory illness. In addition, individuals were questioned directly at the time of blood drawing regarding possible chronic illness. The presence of a chronic inflammatory illness or clinically acute infection at the time of blood drawing excluded individuals from further study. The questionnaire also gathered demographic information such as income level, education level, race, and urban versus rural residence during childhood. Questions were modeled after those used in the U.S. Census (14) . For the children less than 12 years of age, excluding the 9-month-olds, the questionnaire was completed by a parent or guardian. Income and education level reflect those of the parent or guardian in this age group. The questionnaire was not used for the 9-month-old group.
Isolation and Analysis of Peripheral Blood Mononuclear Cells (PBMC)
PBMC were separated from heparinized blood by FicollHypaque (Pharmacia, Chicago, IL) density centrifugation. The samples were analyzed by two-color immunofluorescence using mAbs directed to different Vp and Va gene segments as well as those directed against CD4 and CD8. Biotinylated mAbs used were directed to V(32 ( + expansions are absent or rare in cord blood samples. Using the higher of these two cutoffs, the samples in this study were evaluated for the presence of CD8 + T-cell expansions expressing a particular Vp region.
The presence or absence of an expansion was evaluated as a dichotomous variable. The data were also evaluated by age using the following age groups: 9 months, 4 to 12, 20 to 30, 35 to 50, and 65 to 85 years. The statistical analysis used SAS Software (Statistical Analysis Software, Cary, NC). The main predictor variable in the analysis was age or age group. A frequency analysis of the data computed the prevalence or proportion of individuals with a VP-expressing CD8 + T-cell expansion with 95% confidence intervals for each age group evaluated. The 9-month age group was excluded from additional analyses because no questionnaire data were collected from this age group. Chi-square or Fisher's exact test was used to analyze differences in the prevalence of CD8 + T-cell expansions between age groups, and to analyze differences in demographic and personal illness histories of individuals with and without expansions in each age group. Logistic regression was also used to generate a model for the estimation of the prevalence of the CD8 + T-cell expansions.
RESULTS
Differences in Demographic Characteristics
Between Age Groups A total of 157 individuals from the Denver metropolitan area volunteered for this study. A complete analysis of TCR repertoire using our panel of mAbs was completed for 147 of these individuals, and questionnaire data were collected from 123 subjects (excluding the 9-month-old children). Demographic characteristics such as race, education level, income level, and urban versus rural residence during childhood for the study population as well as a breakdown based on the four age groups from whom these data were collected are shown in Table 1 . A comparison of these characteristics indicates that there are differences in income level, education level, and urban versus rural residence during childhood among the age groups. This most likely reflects selection bias due to the method of recruiting volunteers for this study. Further statistical analysis of these variables and their effect on the presence of a CD8 + T-cell expansion by stratification of the data indicated that these variables did not influence this outcome within any of the age groups (see below). Table 1 also shows the comparison between individuals with and without expansions for each of the demographic characteristics in the questionnaire. No differences were found to be significant aip < .05.
TCR Repertoire Differences Among the Age Groups
An analysis of the TCR V(3 repertoire using the available mAbs was completed for the 147 study participants. The mean (± standard error, SE) percentage of cells expressing each V(3 in both the CD4 + and the CD8 + T-cell populations was calculated for each age group including the 9-monthold subjects (Figure 1) . Overall, the mean percentage for each V(3 subset in the 9-month-old group can be considered to be the baseline for the entire study population. The results show that there is little variability with age in the V(3 subsets in CD4 + T cells. A slight decrease in V(32 + CD4 + T cells was apparent in adults compared to children, and this trend has been noted previously (Ricalton & Kotzin, unpublished observations). In contrast to the CD4 + population, considerable variability was apparent in the CD8 + population of elderly (65-to 85-year-old) adults. This variability reflects the presence of expansions in this particular population (see below) and the changes that they cause in the overall TCR repertoire. The degree of variability in the CD8 + cells increases with age, whereas the CD4 + levels remain in a fairly narrow range across all age groups. Figure 2 details the amount of variability that exists between the age groups for three of the V|3 subsets analyzed. 
10.7
T h e questionnaire was not administered to the 9-month-old age group. Responses regarding income and education for the 4-to 12-year-old group reflect those of the parent or guardian completing the questionnaire for the child, flncome factor is $1,000.
Completing grades less than 12 or not achieving high school diploma. §Completing some college or receiving associate's degree. Professional such as doctor or lawyer. VB Figure 1 . Immunofluorescence staining and cytofluorographic analysis with the different anti-TCR V|} mAb for all study subjects (n = 147). The mean percentage (± SE) of V(3* cells in the CD4* and CD8* populations is shown for each age group. age groups is genetically determined and linked to the TCR 3-cain (TCRB) gene complex (17, 25) .
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Determination of the Prevalence ofT-Cell Expansions
Overall, 20 of the 147 individuals studied had at least one subset expansion in the CD8 + T-cell population, which corresponds to an overall prevalence of 13.6% for this study group. Figure 3 shows the prevalence of CD8 + T-cell expansions in relation to the different age groups. There were no expansions identified in the 9-month-olds (n = 24). Much like cord blood samples, these individuals appear to be devoid of such CD8 + T-cell expansions. An analysis of mean percentages and standard deviations for these 9-month-old individuals showed values remarkably similar to those previously published for cord blood samples by Fitzgerald et al. (2) and Posnett et al. (9) for separate data sets. Thus, the results in this youngest age group appear to support the usefulness of these previously defined cutoffs.
Of the 37 children between 4 and 12 years of age, one expansion was identified in a 7-year-old, corresponding to a prevalence of 2.7% in this particular age group. In the 20-to 30-year-old subjects, 4 of 30 individuals (13.3%) met the criteria for an expansion. Six of the 29 individuals (20.7%) in the 35-to 50-year-old group demonstrated expansions (p < .02 compared to the 9-month group). Finally, for those 27 subjects over the age of 65,15 expansions were found overall and 9 individuals (33.4%) were found to have at least one expansion in the CD8 + T-cell population (p < .001 compared to the 9-month group). As shown in Figure 3 , the prevalence of CD8 + T-cell expansions appeared to increase linearly with age.
The above identification of CD8 + T cell expansions was based on values for cord blood samples (2) , and cutoffs were defined prior to beginning the current study. In a retrospective fashion, we also applied a new cutoff to the current analysis, using the mean percentage + 3 SD for each VfJ Figure 2 . Vertical box plot analysis of the median percentage of total CD4* and CD8* T cells expressing V|33, V|35.2, and V013.1 in each age group. The lower and upper borders of the box represent the 25th and 75th percentiles, and the lower and upper error bars represent the 10th and 90th percentile values, respectively. The lower and upper symbols represent the 5th and 95th percentile values, respectively. The increased spread of percentages for V(33 + cells, compared to other V|3 subsets, in both the CD4* and CD8* populations for all age groups is genetically determined and linked to the TCRB gene complex (17, 25) . In contrast, each of the V(J subsets show an age-related increase in the the number of high percentages in the CD8* population as shown by the position of the 95th percentile bar. subset in the 9-month-old group. These new criteria were more sensitive in that all of the expansions defined above met the new criteria and more elevated values were identified in each age group. The increased prevalence with age was again clear-cut. Using these new cutoffs, we found five expansions in the 4-to 12-year-olds, six expansions in the 20-to 30-year-olds, 14 expansions in the 35-to 50-yearolds, and 41 expansions in the 65-to 85-year-olds. Twenty individuals (74%) of the oldest age group demonstrated at least one elevated value. The clonal basis for these smaller expansions, defined by the less stringent criteria, is untested at this time.
In an analogous fashion, we applied similar cutoffs (i.e., mean percentage + 3 SD of V(3 + cells in the CD4 + population of the 9-month-olds) to the corresponding CD4 Vp + subsets in the older age groups. This analysis identified three elevated values in the 4-to 12-year-olds, one in the 20-to 30- Figure 3 . The prevalence of CD8* T-cell expansions is shown in relation to the mean age of each age group (n = 24 for the 9-month-olds, n = 37 for the 4-to 12-year-olds, n = 30 for the 20-to 30-year-olds, n = 29 for the 35-to 50-year-olds, and n = 27 for the 65-to 85-year-olds). The bracketed areas represent the age range of each group. For the 9-month old children, only that mean age is used in the plot. The 95% confidence intervals for the prevalence values are also presented.
year-olds, four in the 35-to 50-year-olds, and 11 in the 65-to 85-year-old group. Overall, these CD4 + T-cell expansions were smaller in size compared to the CD8 + expansions. For example, the largest expansion in the oldest age group expressed VfS5.2 and was 11.0% of the CD4 + population. These data for CD4
+ subsets are consistent with recent studies by Schwab et al. (26) , who identified relatively frequent but small clonal CD4 + expansions in elderly individuals.
TCR Expression ofCD8* Subset Expansions
The V regions expressed by the CD8 + expansions did not appear to be randomly distributed across the TCR repertoire based on the percentage of cells expressing that particular V region (see Figure 1) . Of 31 expansions identified in 20 individuals, 8 expressed Vp3 and 5 expressed V(35.1, Vp8.1, or Vpl3.1 (Table 2) . Table 2 also indicates the size of the expansions. As previously reported (2,9), some expansions were large, accounting for nearly one-quarter of the total CD8 + T-cell population. Table 3 lists the V(3 expansions in relation to age group. Only individuals over the age of 65 demonstrated expansions expressing more than one V region, and of the 9 individuals with CD8 + T-cell expansions in this age group, 5 subjects had more than one Vp expansion. Fitzgerald et al. (2) identified healthy individuals as well as some rheumatoid arthritis patients with multiple VfJ subset expansions, and all were over the age of 35.
The prevalence of expansions expressing Val2.1 was determined in a separate comparison of the 9-month-old versus 65-to 85-year-old individuals. Six (22.2%) of the 27 individuals in this oldest age category had a Val2.1 expansion, compared to none in the 9-month-old children (p = .02). Expansions expressing Val2.1 were previously shown to be relatively frequent in patients with rheumatoid arthritis (1,2) .
Comparison of Childhood Illnesses and Vaccination Histories
The questionnaire collected information related primarily •All subjects were screened with mAbs to Vp2, Vp3.1, VP5.1, Vp5.2/5.3, Vp6.7, Vp8.1/8.2, Vp9, Vpl3.1, Vpi3.2, Vpi4, Vpi7, and Vp23.
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tTotal number of expansions reflects the fact that some individuals had multiple Vp expansions.
JThe upper cutoff limit represents the higher of the two values used to determine an expansion (see Materials and Methods). •All subjects were screened using mAbs to Vp2, Vp3, VP5.1, Vp5.2/5.3, Vp6.7, Vp8.1/8.2, Vp9, Vpi2, Vpl3.1, Vpl3.2, Vpi4, Vpl7, and VP23. The five subsets shown in the table represent the Vps most frequently utilized by expansions found in this study.
to childhood infectious illnesses, hoping to identify a common exposure among those individuals with CD8 + T-cell expansions. Table 4 compares the responses of those individuals with and without expansions, showing odds ratios and 95% confidence intervals. Results for the oldest age group are also shown separately, since this group was the only one with a reasonable number of individuals with a CD8 + subset expansion. Relatively high mean odds ratios were seen for chicken pox and shingles (herpes zoster/varicella infection), hepatitis B, and infectious mononucleosis (acute Epstein-Barr virus infection) in the total study population. However, only a history of shingles showed an increased mean odds ratio in the elderly group. None of these associations was found to be statistically significant. The number of missing observations due to the inability to remember and the accuracy of the responses due to recall bias were limitations in this questionnaire study.
Statistical Modeling of the Data
Logistic regression was used to generate a model for predicting the presence of a CD8 + T cell expansion in our •Each illness or vaccination corresponds to a question answered on the questionnaire administered to all subjects (excluding the 9-month-old children).
t T h e odds ratio (OR) represents the comparison of having had a particular illness or vaccination for those with a CD8+ T-cell expansion in comparison to those without expansions; 95% confidence intervals which overlap 1.0 are not considered to be statistically significant.
tThe dash indicates that only positive responses were recorded, so confidence intervals were not calculated. study population. A stepwise model was generated that included the following variables: age, income, education level, urban versus rural residence during childhood, and all the infectious exposures from the questionnaire. Age was the only significant variable (p < .001) for predicting the presence of an expansion in this study.
DISCUSSION
This study was designed to determine whether increasing age is a major factor in the development of CD8 + T-cell expansions in healthy individuals. Previous studies from our laboratory (2) and others (9) had suggested a higher prevalence of these expansions in adults compared to children, but selection bias could have accounted for these differences, and the ages of adults with expansions varied greatly. As in our previous study (2), we used immunofluorescence staining and cytofluorographic analysis to determine the percentage of cells expressing a particular TCR V region. It is emphasized that searching for expansions by V region expression primarily identifies large CD8 + subset expansions, i.e., clones that are large enough to alter the percentage of cells expressing a particular V region. We recognize that PCR-based approaches such as CDR3 length analysis (8, 10, 26, 27) and single-stranded conformational polymorphism (28) would be a more sensitive method, and that small clones would be missed by our approach. Still, using a limited set of anti-TCR mAbs, we found that onethird of elderly individuals demonstrated an increased percentage of CD8 + cells expressing a particular V|3 region, which has accurately predicted the presence of a clonal expansion in previous studies (2) . The use of immunofluorescence staining has also predicted clonal expansions that persist in the circulation for long periods of time (2, 9) . Our results clearly demonstrate that aging is associated with an increased prevalence of CD8 + expansions. No expansions were identified in 9-month-old individuals, and mean percentages for VP-expressing subsets for this group were similar for all of the other age groups except the 35-to 50-year-olds and the 65-to 85-year-olds. In the 65-to 85-year-old age group, mean percentages and standard deviations for several CD8 + subsets increased, reflecting individuals with CD8 + expansions expressing those particular V regions. This age-dependent pattern was not apparent in the CD4 + population, consistent with multiple previous reports suggesting that large clonal expansions are confined to the CD8 + population in healthy individuals (2,8-10, 12,29) . However, a recent study by Schwab et al. (26) has identified frequent but small clonal CD4 + expansions in elderly individuals. In addition to the increased prevalence with age, we found that only the oldest individuals had multiple CD8 + expansions expressing different V regions. Considering that our anti-Vp mAbs covered approximately 50% of the CD8 + TCR repertoire, we predict that at least 70% of older individuals harbor large expansions in the CD8 + population and most will have multiple expansions. Although this prediction assumes that the V(3s used by the CD8 + clones are relatively evenly dispersed over the entire repertoire, which does not appear to be totally correct (see below), the estimated prevalence is consistent with previous reports using both immunofluorescence and PCR-based techniques to identify expansions (2, 3, (8) (9) (10) 26, 29, 30 (25) , yet none of the expansions expressed Vpi4(p<.001). The selectivity in V region usage suggests that these T-cell expansions arise in response to stimulation by particular antigens and that they are not just random proliferation events. Consistent with this possibility, previous reports have also noted preferential V region usage (2, 3, 10) . Furthermore, CD8 + expansions among related individuals have been shown to express similar TCRs with the same VB region and similar complementarity determining region 3 (CDR3) sequences (2,10), most consistent with a response to a common antigen. It is interesting to note that Vp3 and Val2.1 have been previously noted to be frequently expressed by clonal CD8 + expansions in patients with rheumatoid arthritis (1-3). Our current results indicate that Vp3 and Val2.1 are also frequently expressed by expansions in normal individuals.
The etiology of the CD8 + expansions in healthy individuals remains unknown. It is of interest that patients infected with HIV frequently demonstrate large clonal CD8 + expansions, and these cells may reflect HIV-specific CTL (4-6). The expansions in HIV-infected individuals have several of the distinctive surface characteristics found on the CD8 + expansions in normal individuals, including lack of CD28 and presence of CD57 (6, 9, (30) (31) (32) . However, increasing age does not appear to be an important factor in the HIV setting, in contrast to the expansions that develop in healthy individuals. The relatively high concentration and persistent stimulation by HIV antigens may be the most important factors in driving the excessive expansion of particular CD8 + clones in HIV-infected individuals. However, it is also interesting to speculate that the immunologic defects in HIV-infected individuals have some similarities with those that develop in aging individuals and are important for the development of the clonal CD8 + expansions. If one assumes that the expansions in healthy individuals do arise in response to particular antigens, most likely infectious in origin, there appear to be two major scenarios to explain the current results. The first is that exposure occurs earlier in life and that continued stimulation and/or subsequent immunologic changes with age allow the emergence of expansions in older individuals. It is also possible that exposure to the stimulating antigen mostly occurs later in life. The occasional expansion in children and in young adults may suggest that the stimulating agent is present early in life and causes an inconsequential or asymptomatic initial infection. Based on this hypothesis, the current study included questionnaire data concerning childhood and adult exposure to a variety of agents, especially ones that would persist in the host, hoping to identify some environmental trigger for these expansions. Analysis of these results did not identify or suggest a single etiologic agent, and increasing age was the only important variable identified. In preliminary studies, we have also attempted to correlate serologic evidence of past herpes virus infection with the presence of an expansion. Individuals with clonal CD8 + Tcell expansions have been identified who do not have positive serology for past exposure to Epstein-Barr virus, cytomegalovirus, varicella-zoster virus, and herpes simplex viruses (Ricalton, Levin, & Kotzin, unpublished observations). These preliminary data and the questionnaire results are consistent with the hypothesis that no single infection is responsible for all of the expansions, but that different agents can result in the eventual emergence of a clonal expansion with age.
In summary, the present results identify age as an important factor in the development of CD8 + expansions in healthy individuals. The results are consistent with studies in normal mice housed under pathogen-free conditions, in which increasing age has been found to be the single most important factor in the spontaneous development of similar large clonal CD8 + expansions (11) . Considering the frequency and size of expansions in elderly individuals, it will be important to understand the mechanisms for their development and their impact on the immune system.
